Monday deadline: acutus medical, inc. investors with substantial losses have opportunity to lead class action lawsuit

San diego, april 14, 2022 /prnewswire/ -- robbins geller rudman & dowd llp announced that purchasers of acutus medical, inc. (nasdaq: afib) common stock between may 13, 2021 and november 11, 2021, inclusive (the "class period") have this upcoming monday, april 18, 2022 to seek appointment as lead plaintiff in the acutus medical class action lawsuit.  robbins geller represents the plaintiff in the first-filed complaint, brown v.
AFIB Ratings Summary
AFIB Quant Ranking